Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Timema douglasi male genome sequencing

PROVIDER: PRJNA808673 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18079118_1.fastq.gz	Fastqsanger.gz
	SRR18079118_2.fastq.gz	Fastqsanger.gz
	SRR18079119_1.fastq.gz	Fastqsanger.gz
	SRR18079119_2.fastq.gz	Fastqsanger.gz
	SRR18079120_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Timema douglasi

Project description:Timema douglasi PacBio genome sequencing

| PRJNA673001 | ENA

Timema douglasi

Project description:Timema douglasi overview

| PRJNA1124212 | ENA

Timema douglasi isolate:not applicable

Project description:Timema douglasi isolate:not applicable Genome sequencing

| PRJNA1123914 | ENA

Timema douglasi (stick insect), genomic data

Project description:Timema douglasi (stick insect), genomic data

| PRJEB75180 | ENA

Timema sp

Project description:Devolopmental RNASeq sequence reads for Timema douglasi and Timema poppense

| PRJNA1128554 | ENA

Project description:Timema sp male genome sequencing

| PRJNA725673 | ENA

Timema knulli isolate:Timema knulli BCE RW

Project description:Timema knulli isolate:Timema knulli BCE RW Genome sequencing

| PRJNA967732 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Timema cristinae

Project description:Timema cristinae Genome sequencing and assembly

| PRJNA417530 | ENA

Project description:Timema supergene whole and partial genome sequencing

| PRJNA638692 | ENA